# As Needed Beclomethasone/Salbutamol Combination in Single Inhaler for Mild Persistent Asthma

> **NCT00382889** · PHASE3 · COMPLETED · sponsor: **Chiesi Farmaceutici S.p.A.** · enrollment: 480 (—)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** beclomethasone/salbutamol combination
- **DRUG:** beclomethasone
- **DRUG:** salbutamol

## Key facts

- **NCT ID:** NCT00382889
- **Lead sponsor:** Chiesi Farmaceutici S.p.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-08
- **Primary completion:** —
- **Final completion:** 2004-09
- **Target enrollment:** 480 (—)
- **Last updated:** 2020-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00382889

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00382889, "As Needed Beclomethasone/Salbutamol Combination in Single Inhaler for Mild Persistent Asthma". Retrieved via AI Analytics 2026-08-12 from https://api.ai-analytics.org/clinical/NCT00382889. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*